Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones02-01 05:44

DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slipped 1.48% to $672.98 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.50% to 6,040.53 and Dow Jones Industrial Average falling 0.75% to 44,544.66.

This was the stock's second consecutive day of losses.

Regeneron Pharmaceuticals Inc. closed 44.44% short of its 52-week high of $1,211.20, which the company achieved on August 27th.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 0.49% to $285.42, Moderna Inc. $(MRNA)$ fell 3.95% to $39.42, and Gilead Sciences Inc. $(GILD)$ rose 0.26% to $97.20.

Trading volume (943,604) eclipsed its 50-day average volume of 878,576.

Data source: Dow Jones Market Data, FactSet. Data compiled January 31, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

January 31, 2025 16:44 ET (21:44 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2508918529?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-01 05:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2508918529","market":"sh","top_or_hot":-1,"title":"Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Regeneron Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/REGN\">$(REGN)$</a> slipped 1.48% to $672.98 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&amp;P 500 Index  falling 0.50% to 6,040.53 and Dow Jones Industrial Average  falling 0.75% to 44,544.66. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Regeneron Pharmaceuticals Inc. closed 44.44% short of its 52-week high of $1,211.20, which the company achieved on August 27th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc. <a href=\"https://laohu8.com/S/AMGN\">$(AMGN)$</a> rose 0.49% to $285.42, Moderna Inc. <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> fell 3.95% to $39.42, and Gilead Sciences Inc. <a href=\"https://laohu8.com/S/GILD\">$(GILD)$</a> rose 0.26% to $97.20. \n</p>\n<p>\n     Trading volume (943,604) eclipsed its 50-day average volume of 878,576. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled January 31, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 31, 2025 16:44 ET (21:44 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-01 05:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REGN","symbol_name":"再生元制药公司","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2508918529","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2508918529","pubTimestamp":1738359840,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  slipped 1.48% to $672.98 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.50% to 6,040.53 and Dow Jones Industrial Average  falling 0.75% to 44,544.66.This was the stock's second consecutive day of losses.Regeneron Pharmaceuticals Inc. closed 44.44% short of its 52-week high of $1,211.20, which the company achieved on August 27th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc.  rose 0.49% to $285.42, Moderna Inc.  fell 3.95% to $39.42, and Gilead Sciences Inc.  rose 0.26% to $97.20.Trading volume  eclipsed its 50-day average volume of 878,576.Data source: Dow Jones Market Data, FactSet. Data compiled January 31, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published inde","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"REGN":"再生元制药公司"},"translate_title":"与竞争对手相比，再生元制药公司股票周五表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REGN":1},"content_text":"DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ slipped 1.48% to $672.98 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.50% to 6,040.53 and Dow Jones Industrial Average  falling 0.75% to 44,544.66. \n\n\n     This was the stock's second consecutive day of losses. \n\n\n     Regeneron Pharmaceuticals Inc. closed 44.44% short of its 52-week high of $1,211.20, which the company achieved on August 27th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 0.49% to $285.42, Moderna Inc. $(MRNA)$ fell 3.95% to $39.42, and Gilead Sciences Inc. $(GILD)$ rose 0.26% to $97.20. \n\n\n     Trading volume (943,604) eclipsed its 50-day average volume of 878,576. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled January 31, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 31, 2025 16:44 ET (21:44 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2508918529"}